Moreover, PDGF-D promotes tumorigenesis and aggressiveness by activating Notch1 pathway in breast and pancreatic cancers [3, 4], but it is unclear whether this also occurs in CRC. Here, NOTCH1 is linked to familial pancreatic carcinoma.